The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...